Discovery Collaboration and License Agreement Sample Contracts

Contract

Discovery Collaboration and License Agreement • August 7th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Discovery Collaboration and License Agreement
• Filed
  August 7th, 2019
• Company
  CytomX Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

DISCOVERY COLLABORATION AND LICENSE AGREEMENT between BICYCLETX LIMITED and GENENTECH, INC. Dated as of February 21, 2020

Discovery Collaboration and License Agreement • March 10th, 2020 • BICYCLE THERAPEUTICS PLC • Pharmaceutical preparations • New York

• Contract Type
  Discovery Collaboration and License Agreement
• Filed
  March 10th, 2020
• Company
  BICYCLE THERAPEUTICS PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Discovery Collaboration and License Agreement (the “Agreement”) is made and entered into effective as of February 21, 2020 (the “Effective Date”) by and between BicycleTx Limited, a company incorporated in England and Wales (“BicycleTx”), and Genentech, Inc., a Delaware corporation (“Genentech”). BicycleTx and Genentech are referred to herein individually as a “Party” and collectively as the “Parties”.

DISCOVERY COLLABORATION AND LICENSE AGREEMENT between HARPOON THERAPEUTICS, INC. and ABBVIE BIOTECHNOLOGY LTD. Dated as of October 10, 2017

Discovery Collaboration and License Agreement • October 24th, 2018 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Discovery Collaboration and License Agreement
• Filed
  October 24th, 2018
• Company
  Harpoon Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Discovery Collaboration and License Agreement (the “Agreement”) is made and entered into effective as of October 10, 2017 (the “Effective Date”) by and between Harpoon Therapeutics, Inc., a Delaware corporation (“Licensor”), and AbbVie Biotechnology Ltd., a Bermuda corporation (“AbbVie”). Licensor and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

AMENDED AND RESTATED DISCOVERY COLLABORATION AND LICENSE AGREEMENT between

Discovery Collaboration and License Agreement • March 12th, 2020 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Discovery Collaboration and License Agreement
• Filed
  March 12th, 2020
• Company
  Harpoon Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)

This Amended and Restated Discovery Collaboration and License Agreement (the “Agreement”) is made and entered into effective as of 20 November, 2019 (the “Amended Effective Date”) by and between Harpoon Therapeutics, Inc., a Delaware corporation (“Harpoon”), and AbbVie Biotechnology Ltd., a Bermuda corporation (“AbbVie”). Harpoon and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”